Jyong Biotech Ltd. Ordinary Shares

MENS | NASDAQ

$1.86

-$0.02 (-1.06%)

Nov 2, 2026, 12:12 PM ET · Market open

TTM Period Ending	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	58K	58K	120K	62K	62K	n/a	n/a
Gross Profit	n/a	-58K	-58K	-120K	-62K	-62K	n/a	n/a
Operating Income	-2.61M	-817.45K	-817.11K	-2.06K	-2.35K	-1.8K	-1.32K	-844
Interest Income	610K	25K	25K	7K	6K	6K	n/a	n/a
Pretax Income	-4.67M	-1.25M	-1.25M	-3.02K	-3.5K	-2.66K	-1.99K	-1.33K
Net Income	-4.67M	-1.25M	-1.25M	-3.02K	-3.5K	-2.66K	-1.99K	-1.33K
Selling & General & Admin	1.79M	450.01K	449.68K	1.13K	1.37K	1.03K	803.50	577.50
Research & Development	813.22K	367.44K	367.43K	927	979.50	765.50	516	266.50
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.61M	817.45K	817.11K	2.06K	2.35K	1.8K	1.32K	844
Interest Expense	2.54M	1M	1M	1.04M	448.69K	448.39K	393	172
Selling & Marketing Expenses	12.50	24	23	44	45	33.50	23	12.50
Cost & Expenses	2.61M	817.45K	817.11K	2.06K	2.35K	1.8K	1.32K	844
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	74.23M	74.26K	71.76M	71.57K	71.57K	71.57K	71.57K	71.57K
Shares Outstanding (Diluted)	74.23M	74.26K	71.76M	71.57K	71.57K	71.57K	71.57K	71.57K
EPS (Basic)	-0.09	-0.05	-0.04	-0.04	-0.05	-0.04	-0.03	-0.02
EPS (Diluted)	-0.09	-0.05	-0.04	-0.04	-0.05	-0.04	-0.03	-0.02
EBITDA	-2.63M	-836.39K	-836.05K	-1.94K	-2.23K	-1.7K	-1.26K	-813
EBIT	-2.63M	-836.45K	-836.11K	-2.06K	-2.35K	-1.8K	-1.32K	-844
Depreciation & Amortization	30	59	58	120	122	93	62	31